In most healthcare systems, contracts dictate daily operations, including what is reimbursed, which supplies are approved, how vendors are held accountable for service levels, and what actions are ...

Best hospitals 2026 Healthgrades lists the top 50 U.S. hospitals for clinical excellence based on Medicare data from 2022 to 2024.

Healthcare is entering another period of significant change. Financial pressure continues to build, while new technologies are moving decisively from pilots to practice. At the same time, policy ...

Benjamin “BJ” Predum has been named Central Coast market president at Dignity Health, effective Feb. 2, according to a news release shared with Becker’s. In the role, Mr. Predum will oversee the ...

Cleveland Clinic reports 18B revenue and nearly 16 million patient visits in 2025, highlighting growth and expanded access under CEO Tom Mihaljevic.

Top workflow pain points frustrating physicians include documentation burden, chart review overload, inbox volume, and fragmented digital tools.

CMS proposed its 2027 Medicare Advantage and Part D capitation rates and payment policies Jan. 26, putting forth a slowdown in payment growth after a $25 billion boost for 2026. Five things to know: ...

While healthcare job gains drove overall U.S. employment growth in December, the sector’s momentum has slowed below its 2024 and 2025 averages. Healthcare added an average of 56,000 jobs per month in ...

Health mon hospitals rebrand to Vandalia Health, unifying signage and patient materials across West Virginia facilities under Vandalia system.

Minneapolis-based Hennepin Healthcare is making service line changes that will result in the elimination of about 100 positions, citing a broader effort to stabilize its finances and protect core ...

As health systems head into 2026 amid margin pressure, policy uncertainty and rising demand, executives are converging around a shared set of priorities. Across responses from CEOs, CFOs and senior ...

As GLP-1 pills for weight loss enter the U.S. market, some pharmaceutical companies are testing the possibility of a gene therapy to stimulate GLP-1 production, The Washington Post reported Jan. 24.